Shyam Allamaneni, MD
Surgical Oncology · Cincinnati, OHNPI 1053553586
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,930 of the $2,693 with a category attached, or 71.7%. 14 manufacturers reported payments, led by Baxter Healthcare at 54.9% of the total. Reporting peaked in 2022 at $1,627 and has fallen 88.5% since, to $188 in 2025.
Across 17 payments — averaging $158.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$1K
- Ethicon Endo-surgery Inc.$450
- Medtronic$359
- Intuitive Surgical$216
- Steris Corporation$34
- Dilon Technologies, Inc.$22
- plus $132 from 8 others
What the payments were for
- Consulting fees$1,93072%
- Food & beverage$76328%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 1 | $1,480 |
| Ethicon Endo-surgery Inc. | 1 | $450 |
| Medtronic | 3 | $359 |
| Intuitive Surgical | 2 | $216 |
| Steris Corporation | 1 | $34 |
| Dilon Technologies, Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Merck | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| Lexington Medical, Inc. | 1 | $17 |
| Avanos Medical | 1 | $16 |
| Axonics, Inc. | 1 | $15 |
| Conmed Corporation | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enseal X1 5mm$450
- Signia$275
- Da Vinci Surgical System$119
How this compares
$2,693 in reported general payments places this provider in the 70th percentile of 69 surgical oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 12 | $6,884 |
| Metoclopramide Hcl | 11 | $124 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Cincinnati
- Syed AhmadCincinnati$59K
- Alicia HeelanCincinnati$9K
- Sameer PatelCincinnati$4K
- Gregory WilsonCincinnati$4K
- Erik Dunki JacobsCincinnati$3K
- Elizabeth ShaughnessyCincinnati$2K
- Kelly McLeanCincinnati$2K
- Be SaitoCincinnati$1K
- Jeffrey SussmanCincinnati$628
- Jennifer MandersCincinnati$248
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.